Observational Comparison of Overall Survival between Phase 1b Orca-T and Registry-Based Post-Transplant Cyclophosphamide Patients

By afschroeder • August 22, 2026

Oliai CH, Gandhi A, Hoeg RT, Muffly L, Srour SA, Mehta RS, Waller EK, Lowsky R, Patel SS, Dholaria B, Pantin J, Salhotra A, McGuirk JP, Gomez-Arteaga A, Faramand R, Tamari R, Holter-Chakrabarty J, Hamilton BK, Jimenez AMJ, Murray J, Killian MS, Pavlova A, Fernhoff NB, McClellan JS, Abedi M, Negrin RS, Meyer EH. Observational Comparison of Overall Survival between Phase 1b Orca-T and Registry-Based Post-Transplant Cyclophosphamide Patients. Transplant Cell Ther. 2026 Aug 21:S2666-6367(26)00678-0. doi: 10.1016/j.jtct.2026.08.037. Epub ahead of print. PMID: 42628650.

Tags: allogeneic hematopoietic stem cell transplantation, graft engineered, Hematologic malignancies, Hematology/Oncology, Myeloablative Conditioning, Orca-T, Publications

Novel Endocrine Therapies: Current Status and Future Directions

Brierley-Green E, Duggirala N, McCann KE, Callahan R, Bardia A, Lipsyc-Sharf M. Novel Endocrine Therapies: Current Status and Future Directions. Clin Breast Cancer. 2026 Aug[...]

Insights on supplement use during cancer care from online Reddit conversations

Waissengrin B, O'Connor K, Shirazipour CH, Ivan FA, Reckamp KL, Gonzalez-Hernandez G, Figueiredo JC. Insights on supplement use during cancer care from online Reddit conversations.[...]

Metastatic Cutaneous Apocrine Carcinoma: Diagnostic and Therapeutic Challenges in a Rare Malignancy

Chan BL, Iguh C, Hwang A, Huang C. Metastatic Cutaneous Apocrine Carcinoma: Diagnostic and Therapeutic Challenges in a Rare Malignancy. Cureus. 2026 Jul 21;18(7):e113113. doi:[...]